|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-31S1
|
$97,935
|
$1,959
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-32S1
|
$99,959
|
$1,999
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-32
|
$1,889,710
|
$37,794
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
Vitamin D, alcohol, and risk of lymphomas in a prospective cohort of women
|
5R03CA135687-02
|
$72,500
|
$21,750
|
Chang, Ellen
|
CANCER PREVENTION INSTIT OF CALIFORNIA
|
|
Virotherapy for Relapsed Refractory Multiple Myeloma
|
5R01CA125614-05
|
$246,204
|
$246,204
|
DISPENZIERI, ANGELA
|
MAYO CLINIC
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-26S1
|
$487,529
|
$4,875
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
ZIA CP010126 00580
|
$85,856
|
$4,293
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
VCU Minority-Based Community Clinical Oncology Program
|
2U10CA052784-20
|
$359,518
|
$3,595
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-20S1
|
$100,001
|
$1,000
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-20S2
|
$197,549
|
$1,975
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-37S1
|
$101,020
|
$2,020
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-37S2
|
$148,912
|
$2,978
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-37
|
$4,795,480
|
$95,910
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-22
|
$2,399,682
|
$95,987
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Using mouse models to probe the relationship of oncogenesis to development and o
|
5U01CA105492-07
|
$688,149
|
$227,089
|
HOLLAND, ERIC
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S1
|
$99,949
|
$3,998
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S2
|
$73,975
|
$2,959
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S3
|
$98,980
|
$3,959
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
5P30CA014089-35
|
$6,464,088
|
$258,564
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-26
|
$1,751,531
|
$17,515
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
University of Colorado Southwest Oncology Group
|
2U10CA042777-23
|
$231,603
|
$13,896
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
Understanding Hemotopoietic Neoplasias using Humanized Mice
|
1R01CA156689-01
|
$531,609
|
$265,805
|
FLAVELL, RICHARD
|
YALE UNIVERSITY
|
|
U10 Full Member Application Affiliated with SWOG
|
2U10CA105409-07
|
$325,685
|
$19,541
|
HERBST, ROY
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Type 1 MAGE vaccine immunotherapy for multiple myeloma
|
5K01CA115917-05
|
$159,624
|
$159,624
|
Cho, Hearn
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Tumor-Infiltrating Donor Derived Lymphocyte Therapy After Allogeneic Transplant
|
ZIC BC 011029
|
$159,656
|
$31,931
|
Hakim, Frances
|
CCR (NCI)
|
|
Tumor Banking for the Southwest Oncology Group
|
3U24CA114748-05S1
|
$1,125,491
|
$112,549
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Transplant cancer match
|
ZIA CP010176 10291
|
$51,619
|
$5,162
|
Engels, Eric
|
DCEG (NCI)
|
|
Transcriptional Functions and Targets of the MMSET Protein of t(4:14) Myeloma
|
5R01CA123204-02
|
$316,438
|
$316,438
|
Licht, Jonathan
|
NORTHWESTERN UNIVERSITY
|
|
TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA035415-27
|
$787,658
|
$15,753
|
MOWAT, REX
|
TOLEDO COMMUNITY HOSPITAL ONCOLOGY PROG
|
|
To establish the BC Cancer Agency - Vancouver Centre as a major SWOG centre
|
1U10CA142559-01
|
$188,304
|
$11,298
|
BLANKE, CHARLES
|
BRITISH COLUMBIA CANCER AGENCY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-17S1
|
$75,066
|
$1,501
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-17S2
|
$100,000
|
$2,000
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-17
|
$5,047,305
|
$100,946
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY
|
|
The Molecular Basis for Bortezomib Activity
|
5R01CA129009-04
|
$304,166
|
$304,166
|
STEWART, ALEXANDER
|
MAYO CLINIC ARIZONA
|
|
The Induction of Gene-specific RNAi Against Cancer-associated Genes
|
ZIA BC 010613
|
$207,153
|
$10,358
|
Caplen, Natasha
|
CCR (NCI)
|
|
The Gulf Coast MBCCOP
|
5U10CA128536-04
|
$499,869
|
$9,997
|
BEEKER, THADDEUS
|
PROVIDENCE HOSPITAL (MOBILE, AL)
|
|
The Genetics of Susceptibility to Mouse Plasma Cell Tumors
|
ZIA BC 010008
|
$330,015
|
$66,003
|
Mock, Beverly
|
CCR (NCI)
|
|
The Brooklyn Minority-Based Community Clinical Oncology Program
|
2U10CA114671-04
|
$534,190
|
$10,684
|
SOLOMON, WILLIAM
|
SUNY DOWNSTATE MEDICAL CENTER
|
|
The Brooklyn Minority-Based Community Clinical Oncology Program
|
3U10CA114671-04S1
|
$99,947
|
$1,999
|
Solomon, William
|
SUNY DOWNSTATE MEDICAL CENTER
|
|
The Brooklyn Minority-Based Community Clinical Oncology Program
|
3U10CA114671-04S2
|
$147,852
|
$2,957
|
Solomon, William
|
SUNY DOWNSTATE MEDICAL CENTER
|
|
Th1/Th2 and Tc1/Tc2 T Cell Subsets in Transplantation Therapy
|
ZIA SC 010288
|
$544,555
|
$136,139
|
Fowler, Daniel
|
CCR (NCI)
|
|
Targeting Proteasome Inhibitor-mediated Resistance in Myeloma
|
1K99CA149140-01
|
$89,955
|
$89,955
|
Kuhn, Deborah
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Targeting cell trafficking as a new therapeutic modality for Multiple Myeloma
|
5R01CA133799-03
|
$354,054
|
$354,054
|
Ghobrial, Irene
|
DANA-FARBER CANCER INSTITUTE
|
|
Synstatin Therapy for Multiple Myeloma
|
1R01CA139872-01A1
|
$418,831
|
$418,831
|
RAPRAEGER, ALAN
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Sweden and Denmark linked registries on hospital discharges and subsequent cancer
|
ZIA CP010183 00560
|
$113,406
|
$5,670
|
Anderson, William
|
DCEG (NCI)
|
|
SunCoast CCOP Research Base at the University of South Florida
|
2U10CA081920-09
|
$1,220,157
|
$36,605
|
KRISCHER, JEFFREY
|
UNIVERSITY OF SOUTH FLORIDA
|
|
Studies in the Janus Cohort
|
ZIA CP010120 02135
|
$138,177
|
$12,436
|
Rothman, Nathaniel
|
DCEG (NCI)
|
|
Stroger Hospital of Cook County, Department of Surgery,*
|
3U10CA095867-08S2
|
$543,572
|
$5,436
|
Lad, Thomas
|
HEKTOEN INSTITUTE FOR MEDICAL RESEARCH
|
|
Stroger Hospital of Cook County, Department of Surgery,*
|
3U10CA095867-08S3
|
$100,000
|
$1,000
|
Lad, Thomas
|
HEKTOEN INSTITUTE FOR MEDICAL RESEARCH
|
|
St. Vincent Hospital Regional Cancer Center CCOP
|
2U10CA095968-09
|
$642,591
|
$6,426
|
SAPHNER, THOMAS
|
ST. VINCENT HOSPITAL
|
Total relevant funding to Multiple Myeloma for this search: $48,458,021
|